Latest Allergen Stories

CHICAGO, Oct. 4, 2012 /PRNewswire/ -- Could it be that those with allergic rhinitis (hay fever) and childhood nasal allergies can finally get a break from their allergies and their allergy shots? Chicago's leading allergy, asthma, and immunology expert, Dr. Brian Rotskoff, who treats a large number of Chicago pediatric allergy patients, is happy to say, "Yes!" (Photo: http://photos.prnewswire.com/prnh/20121004/NY87261 ) Sublingual immunotherapy (SLIT) is a highly effective,...

OXFORD, England, October 4, 2012 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune(R) cat allergy treatment for cat allergen-induced rhinoconjunctivitis. The multinational study in almost 1,200 subjects incorporates input from leading medical experts from Europe and North America, and follows a constructive End of Phase 2 meeting with the US Food...

MCLEAN, Va., Sept. 28, 2012 /PRNewswire-USNewswire/ -- What would you do if faced with a child experiencing a life-threatening allergic reaction? It's a question Allergy & Asthma Network Mothers of Asthmatics' national network of Anaphylaxis Community Experts, or ACE Teams, pose in free training programs for educators, families and policymakers across the country. Knowing the answer could save a life and a lifetime of regret. "Allergies, particularly food allergies, can be...

OXFORD, England, September 27, 2012 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the publication of positive phase II results with its ToleroMune(R) cat allergy treatment in the Journal of Allergy and Clinical Immunology (JACI). The results show that cat allergy patients who received four doses of ToleroMune(R) treatment over 12 weeks maintained a significantly greater improvement in symptoms one year after the start...

Allergy Foundation Releases Annual "Fall Allergy Capitals" Rankings, Louisville is #1 WASHINGTON, Sept. 27, 2012 /PRNewswire-USNewswire/ -- Fall is a time to enjoy beautiful colors and autumn weather outdoors. But for 40 million Americans with seasonal allergies, this time of year brings an unwelcome harvest: trillions of pollen particles traveling through the air right into your eyes, nose and mouth. Allergic rhinitis - also called nasal allergies, seasonal allergies or hay fever -...

BASKING RIDGE, N.J., Sept. 26, 2012 /PRNewswire/ -- Emmy-award winning actress Julie Bowen, known for her comedic role in "Modern Family," is for the first time publicly sharing her family's experience with life-threatening allergies to help drive a national conversation on this serious health issue. Bowen is partnering with Mylan Specialty L.P. to launch Get Schooled in Anaphylaxis(TM), a multi-faceted public health initiative that aims to increase awareness of and preparedness...

OXFORD, England, September 18, 2012 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the appointment of Stewart Sharpe to the newly-created position of Vice President, Commercial Operations. Mr Sharpe, who has extensive experience of leading multinational product launches, will lead Circassia's preparations to commercialise its lead allergy programme. Circassia plans to begin phase III testing of its lead ToleroMune(R)...

Asthma study may prompt review of treatment guidelines, could reduce medication costs New research has shown that the millions of people who use corticosteroids prescribed daily to control mild asthma do no better than those who use them only when symptoms occur. These findings suggest a potential new treatment option that could change international standards of care, reduce patients' pharmacy costs, limit long-term exposure to corticosteroids and enable flexibility in managing the...

OXFORD, England, September 11, 2012 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the appointment of Dr Brett Haumann as Chief Medical Officer. Dr Haumann joins Circassia from GlaxoSmithKline where he was Vice President and Medicines Development Leader responsible for the late-stage development of once-daily inhaled medicines for the treatment of asthma and COPD. "I am delighted Brett has chosen to join...

JACKSON, Mich., Sept. 7, 2012 /PRNewswire/ -- Dawn Food Products, Inc. of Jackson, Michigan is recalling 251, 25-pound buckets of Sam's Club Chunky Cinnamon Streusel because it may contain undeclared milk and soy allergens. People who have an allergy or severe sensitivity to specific type of allergens may run the risk of serious or life-threatening allergic reaction if they consume these products. Sam's Club Chunky Cinnamon Streusel was distributed from July 23, 2012 to September 7,...